Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy.

Wang, Yi; Johnson, Kai Conrad Cecil; Gatti-Mays, Margaret E; Li, Zihai

Wang, Yi; Johnson, Kai Conrad Cecil; Gatti-Mays, Margaret E; Li, Zihai.

Afiliación

Wang Y; Division of Medical Oncology, Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Johnson KCC; Stefanie Spielman Comprehensive Breast Center, Columbus, OH, USA.
Gatti-Mays ME; Division of Medical Oncology, Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. Margaret.Gatti-Mays@osumc.edu.
Li Z; Stefanie Spielman Comprehensive Breast Center, Columbus, OH, USA. Margaret.Gatti-Mays@osumc.edu.

J Hematol Oncol ; 15(1): 118, 2022 08 28.

Article en En | MEDLINE | ID: mdl-36031601

Asunto(s)

Inmunoterapia; Neoplasias; Humanos; Terapia de Inmunosupresión; Células Mieloides; Microambiente Tumoral

Palabras clave

CAR-M; Dendritic cells; Myeloid; Myeloid-derived suppressor cells (MDSCs); Polarization; Proliferation; Recruitment; Reprogramming; Tumor microenvironment; Tumor-associated macrophages (TAMs)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoterapia / Neoplasias Límite: Humans Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google